QUEST DIAGNOSTICS INC (DGX) - Price, trends, fundamentals and chart - Passport to Wall Street

QUEST DIAGNOSTICS INC (NYSE: DGX)

Overview

current price

$135.42

$135.42

change

-2.13 | -1.55%

-2.13 | -1.55%

Yesterday's Close

137.55

open

137.55

volume

1.02 M

30d. avg volume.

1.01 M

1 day

134.13 - 138.61

52 weeks

119.59 - 147.97

p/e

18.36

beta

0.9075

market cap

15.23 B

dividend yield

2.18%

Industry

-

News and Commentary

Quest Diagnostics Reduces COVID Testing Turnaround Time, Increases Genetic Sequencing Quest Diagnostics (DGX&...

C.D.C. to Test Sewage Water to Find Early Coronavirus Outbreaks The widespread, nationwide coronavirus outbreak in the United States is pushing the country's testing infrastructure to its limits in recent months, issuing a dark omen for the c...

Global Population is a Far From Coronavirus Herd Immunity, Says World Health Organization The coronavirus pandemic has infected over 22 million people worldwide. Due to the virus's pervasive spread, many have theorized that country populations will be able to reach he...

Coronavirus Update: World Outbreak Continues to Rise Rapidly, CVS to Open All 1,000 Testing Sites The coronavirus pandemic seems to quickening in pace worldwide this week, with over 800,000 new known infections reported in the last week. It has only been a week since the glob...

Coronavirus Update: United States Surpasses One Million Cases, Health Advisers Warn Against Reopenin... The United States has officially surpassed one million known COVID-19 cases on Tuesday, after just about seven months of social distancing m...

Coronavirus Update: FDA Approves First At Home Sample COVID-19 Test The coronavirus pandemic has begun to test the nations of the world in a way that no other virus has before; Countries are beginning to rest...

DNA Test Sales Have Dropped, Leading to Layoffs Consumer DNA tests used to determine ancestry and health factors grew in popularity for several years, but that

Controversies around Theranos continue; Walgreens tries to distance itself Theranos, a Silicon Valley company that claims it developed an incredibly inexpensive blood testing technology which would upend the industry, faces continuing pressure from inve...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more